Place of ipratropium bromide in cough pharmacotherapy in the course of viral respiratory infections Review article
Article Sidebar
Published:
Dec 31, 2020
Keywords:
ipratropium bromide, cough, efficacy, safety
Main Article Content
Abstract
A cough is an involuntary reflex or triggered by a deliberately strenuous exhalation maneuver consisting in the sudden expulsion of air from the lower respiratory tract to remove the residual secretion or a foreign body. When choosing a drug for the treatment of cough, numerous elements should be taken into account, which are intended to maximize the effectiveness of the treatment used and reduce the risk of side effects. One drug that can be used to treat symptomatic treatment of dry cough is ipratropium bromide.
Article Details
How to Cite
Woroń , J. (2020). Place of ipratropium bromide in cough pharmacotherapy in the course of viral respiratory infections. Medycyna Faktow (J EBM), 13(4(49), 445-448. https://doi.org/10.24292/01.MF.0420.9
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Jones BF, Stewart MA. Duration of cough in acute upper respiratory tract infections. Aust Fam Physician. 2002; 31(10): 971-3.
2. Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet. 2008; 371(9621): 1364-74. https://doi.org/10.1016/S0140-6736(08)60595-4.
3. Higenbottam T. Chronic cough and the cough reflex in common lung diseases. Pulm Pharmacol Ther. 2002; 15(3): 241-7. https://doi.org/10.1006/pupt.2002.0341.
4. Widdicombe J, Fontana G. Cough: what’s in a name? Eur Respir J. 2006; 28(1): 10-5. https://doi.org/10.1183/09031936.06.00096905.
5. Morice AH, Fontana GA, Belvisi MG et al. European Respiratory Society (ERS). ERS guidelines on the assessment of cough. Eur Respir J. 2007; 29(6): 1256-76. https://doi.org/10.1183/09031936.00101006.
6. Irwin RS, Pratter MR, Brightling CE et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 suppl): 1S-23S. https://doi.org/10.1378/ chest.129.1_suppl.1S.
7. Morice AH, Fontana GA, Sovijarvi ARA et al. The diagnosis and management of chronic cough. Eur Respir J. 2004; 24(3): 481-92. https://doi.org/10.1183/09031936.04.00027804.
8. Pratter MR. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 suppl): 63S-71S. https://doi.org/10.1378/chest.129.1_ suppl.63S.
9. De Diego A, Martínez E, Perpiñá M et al. Airway inflammation and cough sensitivity in cough-variant asthma. Allergy. 2005; 60(11): 1407-11. https://doi.org/10.1111/j.1398-9995.2005.00609.x.
10. Wirfs MJ. Prescribing Drug Therapy 2020. Springer Publishing Company, New York 2020.
11. Tymiński R, Woroń J (ed). Niekorzystne interakcje leków, aspekty kliniczne i prawne. Medical Tribune Polska, Warszawa 2020.
12. Pounsford JC, Birch MJ, Saunders KB. Effect of bronchodilators on the cough response to inhaled citric acid in normal and asthmatic subjects. Thorax. 1985; 40(9): 662e7.
13. Holmes PW, Barter CE, Pierce RJ. Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection. Respir Med. 1992; 86: 425-9.
14. Zanasi A, Lecchi M, Del Forno M et al. A randomized, placebo-controlled, double-blind trial on the management of post-infective cough by inhaled ipratropium and salbutamol administered in combination. Pulm Pharmacol Ther. 2014; 29(2): 224-32.
15. Morice AH. Epidemiology of cough. Pulm Pharmacol Ther. 2002; 15: 253-9.
2. Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet. 2008; 371(9621): 1364-74. https://doi.org/10.1016/S0140-6736(08)60595-4.
3. Higenbottam T. Chronic cough and the cough reflex in common lung diseases. Pulm Pharmacol Ther. 2002; 15(3): 241-7. https://doi.org/10.1006/pupt.2002.0341.
4. Widdicombe J, Fontana G. Cough: what’s in a name? Eur Respir J. 2006; 28(1): 10-5. https://doi.org/10.1183/09031936.06.00096905.
5. Morice AH, Fontana GA, Belvisi MG et al. European Respiratory Society (ERS). ERS guidelines on the assessment of cough. Eur Respir J. 2007; 29(6): 1256-76. https://doi.org/10.1183/09031936.00101006.
6. Irwin RS, Pratter MR, Brightling CE et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 suppl): 1S-23S. https://doi.org/10.1378/ chest.129.1_suppl.1S.
7. Morice AH, Fontana GA, Sovijarvi ARA et al. The diagnosis and management of chronic cough. Eur Respir J. 2004; 24(3): 481-92. https://doi.org/10.1183/09031936.04.00027804.
8. Pratter MR. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 suppl): 63S-71S. https://doi.org/10.1378/chest.129.1_ suppl.63S.
9. De Diego A, Martínez E, Perpiñá M et al. Airway inflammation and cough sensitivity in cough-variant asthma. Allergy. 2005; 60(11): 1407-11. https://doi.org/10.1111/j.1398-9995.2005.00609.x.
10. Wirfs MJ. Prescribing Drug Therapy 2020. Springer Publishing Company, New York 2020.
11. Tymiński R, Woroń J (ed). Niekorzystne interakcje leków, aspekty kliniczne i prawne. Medical Tribune Polska, Warszawa 2020.
12. Pounsford JC, Birch MJ, Saunders KB. Effect of bronchodilators on the cough response to inhaled citric acid in normal and asthmatic subjects. Thorax. 1985; 40(9): 662e7.
13. Holmes PW, Barter CE, Pierce RJ. Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection. Respir Med. 1992; 86: 425-9.
14. Zanasi A, Lecchi M, Del Forno M et al. A randomized, placebo-controlled, double-blind trial on the management of post-infective cough by inhaled ipratropium and salbutamol administered in combination. Pulm Pharmacol Ther. 2014; 29(2): 224-32.
15. Morice AH. Epidemiology of cough. Pulm Pharmacol Ther. 2002; 15: 253-9.